UB Therapeutics
Active
· 2023UB Therapeutics
About
UB Therapeutics is a biotechnology company focused on developing a novel therapy for the treatment of multiple myeloma. Multiple Myeloma (MM) is the second most common cancer that affects blood cells, with a 5-year survival rate of ~50%.
Tags
Performance
Company Timeline
No timeline data for this period
Score Breakdown
25Traction
0Team
30Visibility
9Profile
50Community
0Discussion (0)
Join the discussion
No comments yet. Be the first to share your thoughts!
Frequently Asked Questions
What does UB Therapeutics do?
UB Therapeutics is a biotechnology company focused on developing a novel therapy for the treatment of multiple myeloma. Multiple Myeloma (MM) is the second most common cancer that affects blood cells, with a 5-year survival rate of ~50%.
When was UB Therapeutics founded?
UB Therapeutics was founded in 2023.
What industry does UB Therapeutics operate in?
UB Therapeutics operates in Life Sciences, Biotech, Oncology, Therapeutics.